Title of article :
Effects of Pomegranate and Spearmint Syrup on Nausea and Vomiting During
Pregnancy: A Randomized Controlled Clinical Trial
Author/Authors :
Mehrabani Mitra نويسنده , Hashem Dabaghian Fataneh نويسنده Research Institute for Islamic and Complementary Medicine, Tehran University of Medical Sciences, Tehran, Iran , Mokaberinejad Roshanak نويسنده School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. , Sadeghpour Omid نويسنده School of Traditional Iranian Medicine, Iran University of
Medical Sciences, Tehran, IR Iran , Abdolhosseini Shahrbanoo نويسنده Department of Traditional Medicine, School of Traditional
Medicine, Kerman University of Medical Sciences, Kerman,
Iran
Abstract :
Background Nausea and vomiting during pregnancy (NVP) affects
approximately 50% - 80% of expecting mothers. NVP can impose negative
effects on the quality of life; therefore, more attention should be paid
to improve patients’ health outcomes. Objectives The purpose of this
trial was to evaluate the efficacy of pomegranate and spearmint syrup on
NVP. Methods In this randomized clinical trial, 74 pregnant women with
moderate NVP were divided into 2 groups via block randomization method.
A total of 24 and 31 patients were analyzed in the syrup and vitamin B6
groups, respectively. The 24-hour pregnancy-unique quantification of
emesis (PUQE-24) scale was used to examine the severity of NVP. The
intervention included the use of pomegranate syrup (5 cc/TDS) plus
vitamin B6 in the syrup group; on the other hand, the control group only
received B6 tablets (20 mg/TDS) for 1 week. The subjects were
followed-up for 1 week without any interventions. Data were analyzed,
using Chi square test for qualitative variables, t test and Mann-Whitney
U test for quantitative variables, and Friedman test for repeated
measures. Results There was no significant difference between the groups
in terms of demographic and pregnancy characteristics. The mean PUQE-24
score in the syrup group was 9.4 ± 1.8 at baseline, 4.6 ± 1.5 on day 7,
and 4.8 ± 2.6 on day 14 (P < 0.001). The mean PUQE-24 score in
the control group was 8.5 ± 1.5 at baseline, 6 ± 2.3 on day 7, and 6.2 ±
2.6 on day 14 (P < 0.001). Although a major decline in PUQE-24
scores was observed in both groups, it was more significant in the syrup
group (P = 0.001). Also, the PUQE-24 score was significantly lower in
the syrup group, compared to the control group on days 7 and 14 (P =
0.02). The visual analog scale scores also showed a greater reduction in
the syrup group, compared to the control group (4.7 ± 2.8 vs. 1.6 ± 3; P
= 0.001). No significant difference was observed between the groups
regarding the duration of nausea, frequency of vomiting, and frequency
of retching; also, no complications were reported. Conclusions The
effectiveness of pomegranate and spearmint syrup in reducing NVP was
confirmed in the syrup group versus the control group with significant
differences.
Journal title :
Astroparticle Physics